Outcomes | End-line (June 2016) | Effect of SG-intervention (95% CI)a | p-value | Effect of combined intervention (SG+) (95%CI)a | p-value | ||
---|---|---|---|---|---|---|---|
Control (%) | SG-intervention (%) | Combined intervention (SG+) (%) | |||||
Logistic models (binary outcomes) | |||||||
Persistenceb of stunting | 20 (37.7) | 10 (34.5) | 14 (36.8) | 0.57 (0.13–2.60) | 0.47 | 0.78 (0.18–3.25) | 0.73 |
Persistence of thinness | 8 (24.2) | 4 (25.0) | 4 (36.4) | 1.36 (0.22–8.29) | 0.74 | 3.50 (0.43–28.74) | 0.24 |
Persistence of overweight | 4 (66.7) | 0 (0.0) | 1 (14.3) | n/a | n/a | ||
Persistence of anaemia | 32 (52.5) | 23 (67.6) | 30 (47.6) | 2.21 (0.74–6.62) | 0.15 | 0.70 (0.27–1.81) | 0.46 |
Incidence of stunting | 31 (14.3) | 22 (16.3) | 21 (13.7) | 0.60 (0.28–1.29) | 0.19 | 0.60 (0.24–1.49) | 0.27 |
Incidence of thinness | 11 (4.70) | 13 (8.8) | 15 (8.3) | 2.06 (0.81–5.21) | 0.13 | 3.07 (1.10–8.61) | 0.03 |
Incidence of overweight | 14 (5.3) | 6 (3.7) | 6 (3.3) | 0.38 (0.86–1.65) | 0.20 | 0.58 (0.13–2.61) | 0.48 |
Incidencec of anaemia | 79 (38.0) | 49 (37.7) | 31 (24.2) | 1.20 (0.43–3.33) | 0.73 | 0.56 (0.16–1.90) | 0.35 |
Linear model (continuous outcomes)d | |||||||
Change in height-for-age (for stunting) | −0.02 (−0.24, 0.19) | −0.16 (0.44, 0.13) | 0.19 (−0.09, 0.46) | 0.05 (−0.46–0.56) | 0.85 | 0.41 (−0.17–0.98) | 0.41 |
Change in BMI-for age (for thinness) | 1.58 (1.14, 2.02) | 0.94 (0.35, 1.54) | 1.02 (0.44, 1.59) | −0.98 (−1.74- (− 0.22)) | 0.01 | − 0.64 (−1.49–0.22) | 0.14 |
Height gain (cm) | 5.20 (3.98, 6.43) | 3.20 (1.59, 4.81) | 6.84 (5.33, 8.35) | −0.52 (−2.67–1.63) | 0.64 | 2.88 (− 0.54–5.23) | 0.02 |
Weight gain (kg) | 6.16 (5.11, 7.21) | 3.50 (2.09, 4.91) | 5.75 (4.42, 7.09) | −2.15 (−4.55- (−0.26)) | 0.08 | 0.22 (− 2.47–2.92) | 0.87 |
Change in haemoglobin level (g/dl) | −0.64 (− 0.98, − 0.30) | −0.60 (− 1.06, − 0.13) | −0.03 (− 0.48, 0.42) | −0.03 (− 0.78–0.72) | 0.94 | 0.58 (− 0.26–1.43) | 0.18 |